Bill > HB06609

This bill proposes several restrictions on medical treatments for minors experiencing gender dysphoria or gender incongruence. Specifically, the bill would prohibit healthcare providers from prescribing puberty blocking drugs or cross-sex hormones to individuals under 18 years old for uses not explicitly approved by the Federal Food and Drug Administration (FDA), which includes treatments related to gender dysphoria. Additionally, the bill would ban surgical interventions for minors intended to address gender dysphoria or perform sex reassignment procedures. Instead of these medical interventions, the bill promotes psychotherapy as an alternative approach for minors dealing with stress associated with gender dysphoria or incongruence. The stated purpose of the bill is to protect the best interests of minors by limiting medical treatments that could potentially have long-term consequences before they reach adulthood. The legislation represents a significant potential restriction on gender-affirming medical care for transgender and gender-questioning youth, focusing on preventing medical interventions until patients are 18 years old.

Health and Social Services

https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB06609&which_year=2025